MedTrace Logo

Patient's Management Receiving Eplerenone Therapy

NCT01440049 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 160

Last updated 2018-12-19

Study results available
· View outcomes & findings →

Summary

On a population of patients followed by an office-based cardiologist and treated with eplerenone, the objectives of the survey are:

* To describe the characteristics of the population treated.
* To describe the methods of use of eplerenone (posology, duration of treatment, medicinal combinations).
* To describe the follow-up methods of the treatment.
* To describe the possible interruptions of the treatment

Conditions

  • Left Ventricular Dysfunction Post Myocardial Infarction

Interventions

OTHER

Prospective Observational

this is an observational study non interventional

Sponsors & Collaborators

Principal Investigators

  • Pfizer CT.gov Call Center · Pfizer

Eligibility

Min Age
18 Years
Max Age
95 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2008-09-30
Primary Completion
2010-12-31
Completion
2010-12-31

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01440049 on ClinicalTrials.gov